- Record: found
- Abstract: found
- Article: not found
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
2003-10-31
Administration, Oral, Adult, Aged, Algorithms, Blood Glucose, drug effects, Body Weight, Diabetes Mellitus, Type 2, drug therapy, Drug Therapy, Combination, Female, Humans, Hypoglycemia, chemically induced, Hypoglycemic Agents, administration & dosage, adverse effects, Insulin, analogs & derivatives, Insulin, Isophane, Insulin, Long-Acting, Male, Middle Aged, Treatment Outcome
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Related collections
Author and article information
Administration, Oral,Adult,Aged,Algorithms,Blood Glucose,drug effects,Body Weight,Diabetes Mellitus, Type 2,drug therapy,Drug Therapy, Combination,Female,Humans,Hypoglycemia,chemically induced,Hypoglycemic Agents,administration & dosage,adverse effects,Insulin,analogs & derivatives,Insulin, Isophane,Insulin, Long-Acting,Male,Middle Aged,Treatment Outcome
Administration, Oral, Adult, Aged, Algorithms, Blood Glucose, drug effects, Body Weight, Diabetes Mellitus, Type 2, drug therapy, Drug Therapy, Combination, Female, Humans, Hypoglycemia, chemically induced, Hypoglycemic Agents, administration & dosage, adverse effects, Insulin, analogs & derivatives, Insulin, Isophane, Insulin, Long-Acting, Male, Middle Aged, Treatment Outcome